Epicardium: Pericarditis Myocardium: Myocarditis, Cardiomyopathy, Myocardial Infarction Endocardium: Endocarditis, Rheumatic Heart Disease
Myocardial degeneration is a broad term for deterioration or structural injury in heart muscle, not a synonym for a heart attack. The phrase describes a change in tissue, while the named conditions in the title refer to different heart layers or disease processes. Those terms are not interchangeable. A heart attack is one specific event that can injure the heart muscle; other conditions involve inflammation, changes in muscle structure, infection, or valve damage.
If you have symptoms or are trying to understand a diagnosis, these distinctions can help you follow conversations about your heart health. The sections below separate the conditions by what they affect, while keeping their possible effects on blood flow and heart function in view. New or severe chest pain, fainting, or trouble breathing warrants prompt medical attention.

Key Takeaways
- Myocardial degeneration describes heart-muscle tissue change, not one uniform illness.
- The epicardium, myocardium, and endocardium are the heart wall’s three main layers.
- The pericardium is the sac around the heart, distinct from the epicardium.
- Myocarditis is inflammation; cardiomyopathy refers to a group of muscle diseases.
- A heart attack results from a sudden loss of coronary blood flow.
- Heart conditions affecting valves, muscle, or surrounding tissue need different care.
How the Heart Wall’s Three Layers Differ
Picture the heart wall as three layers, with a protective sac around the outside. Each layer has a different role, and the pericardium is a surrounding structure, not one of those layers. The heart wall has three main layers: the epicardium, myocardium, and endocardium.

| Structure | Location | Main role | Related condition |
|---|---|---|---|
| Epicardium | Outer heart wall, inside the pericardium | Outer layer of the heart wall | Pericarditis affects the surrounding pericardium |
| Myocardium | Middle layer of the heart wall | Contracts to pump blood | Myocarditis and cardiomyopathy |
| Endocardium | Inner surface of the heart chambers and valves | Lines chambers and valves | Endocarditis |
The epicardium and the pericardium
The epicardium forms the heart wall’s outer layer. The pericardium is the sac surrounding the heart, and it helps protect and hold the organ in place. Pericarditis means inflammation of that sac, not inflammation of the epicardium itself.
The terms can sound alike, but they name different structures. The epicardium is part of the heart wall; the pericardium wraps around the heart. This distinction helps explain why pericarditis is not the same as disease centered in heart muscle.
The myocardium and its pumping muscle
The myocardium is the heart wall’s middle layer of muscle that contracts to pump blood. Its repeated contractions move blood through the heart and into circulation. Myocarditis is inflammation of the myocardium, while cardiomyopathy describes a group of diseases that change heart-muscle structure or function.
Damage to this layer can affect the heart’s ability to pump or its electrical signals. A condition involving muscle tissue does not automatically mean that blood flow through a coronary artery has been blocked.
The endocardium and the heart’s inner lining
The endocardium is a thin lining along the inside of the heart chambers and valves. Its smooth surface helps blood flow through the heart. Endocarditis is an infection of the inner lining or valves, and it can have serious effects beyond the heart.
Keep the pericardium and epicardium distinct: one surrounds the heart, while the other is its outer wall layer.
What Does Myocardial Degeneration Mean?
The term describes changes in heart-muscle tissue, but it does not identify one cause or predict one course. Degeneration is a description of tissue change, not a complete clinical diagnosis. Symptoms, causes, and care depend on the underlying condition.

The phrase may refer to different kinds of structural change. It does not establish whether someone has heart failure, explain what caused the change, or show how much the heart’s pumping ability is affected. A clinician considers the person’s history and findings to identify the condition behind the description.
In ICD-10-CM, code I51.5 applies to fatty or senile degeneration of the heart or myocardium. The 2027 edition took effect October 1, 2026. When the condition is related to hypertension, coding falls under I11 or I13 instead.
An ICD-10-CM code classifies a condition; it does not diagnose a person by itself. The code is used for classification and records. It cannot replace the clinical details needed to decide what tissue change means for an individual’s health or care.
A 1977 study, “Myocardial Degeneration in Congenital Heart Disease,” compared 11 patients aged 1-5 with 8 patients aged 30-53. In the older group, 5 had right ventricular failure, 3 had clinically significant arrhythmias, and 3 died after surgery.
That small, specific group illustrates how prolonged strain in congenital heart disease may be associated with tissue changes and serious complications. It is not a general estimate for people with other heart conditions. A clinician needs the specific diagnosis and underlying cause, not just the word “degeneration,” to guide care.
Myocarditis and Cardiomyopathy Damage the Heart Muscle in Different Ways
Inflammation and cardiomyopathy can both impair the heart muscle, but they describe different kinds of disease. Myocarditis is inflammation, while cardiomyopathy names a group of disorders affecting muscle structure or function. Either can weaken the heart’s pumping ability or disrupt its electrical system.

Myocarditis is inflammation of the myocardium
Myocarditis is inflammation of the myocardium. It can weaken the heart’s pumping ability and affect the electrical system that controls the heartbeat. Possible causes fall into four broad groups:
- Viral, bacterial, or fungal infections
- Medications
- Autoimmune disorders
- Toxic substances
The cause and severity can shape how much the condition affects heart function. During active myocarditis, competitive sports may need to be avoided while inflammation is present. The safe timing for a return to exercise depends on medical assessment, not fitness level alone.
Cardiomyopathy changes the heart muscle’s structure or function
Cardiomyopathy includes dilated, hypertrophic, restrictive, ischemic, and arrhythmogenic right ventricular forms. Researchers have identified more than 1,000 genetic variations that cause cardiomyopathies. Some forms are inherited, while others are linked to other heart conditions or causes.
Tissue findings can also differ. Dilated cardiomyopathy may show enlarged heart-muscle cells, called myocyte hypertrophy, along with degeneration and interstitial fibrosis, or scarring between cells. Myocarditis instead shows myocyte necrosis, meaning cell death, and lymphocytic infiltration, an influx of immune cells.
These patterns help distinguish diseases, but no single tissue feature explains every person’s symptoms or course. Exercise decisions also differ by diagnosis and current heart function. Anyone with active myocarditis should follow their clinician’s advice about sports and strenuous activity.
How a Heart Attack Injures the Myocardium
A heart attack occurs when an acute blockage cuts off coronary blood flow and heart muscle begins to die. The injury follows a loss of oxygen to the myocardium. Myocardial infarction means heart-muscle death caused by an acute blockage of a coronary artery.

Reduced coronary blood flow can become an infarction
Myocardial ischemia occurs when reduced blood flow through a coronary artery limits oxygen to the heart muscle. Atherosclerotic plaque can narrow an artery; if plaque ruptures, a blood clot may form and cause an acute blockage. Ischemia describes reduced oxygen supply, while infarction means muscle tissue has died.
The difference matters because reduced flow does not always mean that muscle has already died. A severe or lasting blockage can progress from ischemia to infarction. In the United States, someone has a heart attack every 40 seconds, and about 805,000 people have one each year.
Of those annual heart attacks, about 605,000 are first events and 200,000 are repeat events. About 1 in 5 heart attacks are silent, meaning they occur without recognized symptoms. The table shows how the terms describe different effects.
| Condition | Blood-flow change | Heart-muscle effect | Typical concern |
|---|---|---|---|
| Myocardial ischemia | Reduced coronary blood flow | Oxygen supply is limited | May progress to injury |
| Myocardial infarction | Acute coronary artery blockage | Muscle tissue dies | Heart attack |
| Silent ischemia | Reduced coronary blood flow without recognized symptoms | Oxygen supply is limited | Injury may go unnoticed |
Symptoms can be absent or atypical
Common symptoms include chest pressure or pain, shortness of breath, sweating, nausea, and pain in an arm, jaw, or neck. Symptoms can be less typical or absent, so a lack of dramatic chest pain does not rule out an event.
Severe or persistent chest pain is an emergency, even when the cause is not yet clear. Treat severe or persistent chest pain as an emergency and call 911.
U.S. Heart Attack and Heart Failure Mortality Trends
The combined U.S. mortality rate for myocardial-infarction- and heart-failure-related deaths fell substantially from 1999 to 2024, then leveled off. The age-adjusted rate declined from 15.32 per 100,000 in 1999 to 7.55 in 2024. Age adjustment helps compare populations with different age structures.

From 1999 to 2024, the United States recorded 552,835 deaths related to myocardial infarction and heart failure among adults aged 25 and older. The mean age-adjusted mortality rate for those deaths was 9.73 per 100,000 people.
The rate fell by an annual 5.39% from 1999 to 2012 and stayed relatively stable afterward. A projection puts the rate at 8.41 per 100,000 in 2035, with a 95% confidence interval of 7.46-9.31. A projection is an estimate, not a guaranteed outcome.
Rates also differed across population groups and regions. The table gives mean age-adjusted rates for 1999-2024; each figure is a comparison within the named category.
| Population or period | Mean age-adjusted rate per 100,000 | Measure |
|---|---|---|
| Men | 12.33 | Sex comparison, 1999-2024 |
| Women | 7.87 | Sex comparison, 1999-2024 |
| Non-Hispanic Black people | 10.59 | Race/ethnicity comparison, 1999-2024 |
| The South | 10.52 | Region comparison, 1999-2024 |
| The Northeast | 8.34 | Region comparison, 1999-2024 |
Across the listed racial and ethnic groups, the mean rate was 9.92 for non-Hispanic White people and 7.70 for Hispanic people. The South had the highest regional mean rate, while the Northeast had the lowest.
These figures describe deaths related to myocardial infarction and heart failure among adults aged 25 and older. A separate measure shows that 919,032 people in the United States died from cardiovascular disease in 2023, equal to 1 in every 3 deaths.
Those measures cover different time frames and categories, so they should not be treated as the same statistic. Keep the 2023 all-cardiovascular-disease death count separate from the longer-term combined heart-failure and infarction measure.
Pericarditis Affects the Sac Around the Heart
Sharp chest pain that changes with breathing or position can point to inflammation around the heart rather than injury within its muscle. Pericarditis is inflammation of the pericardium, the sac surrounding the heart. Fluid around the heart can sometimes progress to cardiac tamponade, a life-threatening compression of the heart.

The pain is often sharp and may worsen with a deep breath or while lying down. Sitting forward may ease it. These features can help clinicians consider pericarditis, but chest pain can have other causes and needs appropriate assessment.
Acute pericarditis is generally defined as lasting up to 4 weeks. Clinicians may use an electrocardiogram, or ECG, to check the heart’s electrical activity. An echocardiogram uses sound waves to show the heart and can help identify fluid around it.
Blood tests may add information about inflammation or other signs of illness. No single test provides every answer; clinicians interpret results alongside symptoms and examination findings. The tests also help assess whether fluid is affecting the heart’s ability to fill and pump.
Treatment depends on the cause and severity. In appropriate cases, anti-inflammatory medicines such as colchicine may be used. Other care may be needed when an underlying cause or a serious complication requires attention.
A pericardial effusion is fluid collected around the heart. If that fluid compresses the heart and interferes with its function, the condition is called cardiac tamponade and needs urgent treatment. Fainting, severe breathlessness, or rapidly worsening symptoms need urgent medical assessment.
How Rheumatic Fever Can Damage Heart Valves
Rheumatic fever can appear weeks after a group A strep infection, even after the throat symptoms have passed. The delay matters: it can develop about 1-5 weeks after infection. Rheumatic fever is the post-strep inflammatory illness; rheumatic heart disease is lasting heart-valve damage that can follow it.

Group A strep can trigger rheumatic fever
Rheumatic fever can follow untreated or improperly treated strep throat, scarlet fever, or impetigo caused by group A Streptococcus. It most commonly affects children ages 5-15. It is rare in children younger than 3 and in adults.
The illness is not the same as the original infection. It can arise after the infection’s throat symptoms have ended, which is why timing can help clinicians assess a possible case. A history of recent infection is one part of the evaluation, not proof by itself.
Rheumatic heart disease can leave lasting valve damage
Rheumatic heart disease can weaken heart valves and interfere with blood moving through the heart. Damage may be lasting. Severe cases may require heart surgery and can result in death.
Evaluation can include blood tests for antibodies to a recent group A strep infection. An echocardiogram can show heart structure and valve function, while an ECG checks electrical activity. A throat swab may help identify an active strep infection.
Clinicians consider these findings together because a single test cannot describe every part of the illness. The distinction between the post-strep illness and lasting valve damage also helps clarify what a diagnosis means and what follow-up may be needed.
Promptly completing prescribed treatment for group A strep is an important way to reduce the chance of rheumatic fever.
Infective Endocarditis Requires Urgent, Team-Based Care
An infection involving the heart’s inner lining can become life-threatening and needs coordinated medical care. Infective endocarditis is a serious infection of the endocardium or heart valves. Clinicians combine clinical findings, microbiology, and imaging rather than relying on one clue.

Infection of the inner lining can threaten the whole body
Endocarditis can affect the heart and other parts of the body. It carries substantial short- and long-term risks for patients who survive an initial episode. Prompt assessment matters because the infection can become severe and care may involve several specialties.
The American Heart Association’s 2023 Duke-ISCVID criteria help clinicians assess suspected endocarditis. The criteria incorporate molecular techniques for identifying pathogens and additional imaging methods. Clinicians interpret those results alongside a patient’s symptoms, examination, and other test findings.
Coordinated expertise guides complex care
A multidisciplinary endocarditis team brings together expertise for diagnosis and treatment decisions. Team members may vary with the patient’s needs, but coordinated input can connect infection care with heart, brain, and other health concerns.
- Cardiology and cardiovascular surgery
- Infectious diseases and clinical microbiology
- Neurology and radiology
- Primary care, dentistry, pharmacy, and nursing
- Addiction-medicine expertise for patients who inject drugs
Clinical microbiology can help identify the organism, while imaging may show heart or valve effects. Cardiovascular surgery can advise when an operation is being considered. Neurology, primary care, and other team members contribute when a patient’s situation calls for their expertise.
Care should account for the whole person, including health needs that may affect recovery. Include addiction-medicine expertise when caring for a patient with endocarditis who injects drugs.
Diagnosis and Treatment Depend on the Specific Condition
The right test depends on whether the clinician needs to check heart rhythm, structure, blood flow, or tissue. Tests answer different questions, and the suspected condition guides the choice. No single test is right for every cause of heart-muscle change.
Tests answer different clinical questions
An electrocardiogram checks electrical activity, while an echocardiogram shows the heart’s structure and pumping function. A heart MRI can provide images of structure and tissue. A rhythm monitor tracks heartbeats over time, and an exercise test checks how the heart responds to activity.
Cardiac catheterization can help assess blood flow and pressure inside the heart. For cardiomyopathy, a clinician may choose an ECG, echocardiogram, heart MRI, rhythm monitor, exercise test, cardiac catheterization, or myocardial biopsy. A biopsy may be used to check for disease.
The tests are selected to address a particular clinical question, such as whether the heart’s shape has changed or its rhythm is abnormal. The results help clinicians connect findings with symptoms and decide whether additional assessment is needed.
Treatment targets the cause and protects heart function
Treatment depends on the diagnosis, cause, and severity. Cardiomyopathy care may include medication, lifestyle changes, cardiac rehabilitation, implantable devices, or surgery. Myocardial ischemia may be treated with medication, angioplasty, or bypass surgery.
For some people, a supervised rehabilitation plan can support a safe return to physical activity. Others may need a device or procedure to address a specific problem. Treatment choices can change as heart function and symptoms change over time.
Ask the treating clinician which activity level is safe for your specific diagnosis.
For a routine appointment, a short written note can make the conversation more useful. Bring these details:
- When symptoms happen and what seems to trigger them
- Current medications and supplements
- Relevant family history
- Questions about safe activity
Include changes in symptoms or activity tolerance in your notes, even when they seem small. Ask the treating clinician which activity level is safe for your specific diagnosis.
Conclusion
The heart’s outer covering, muscle, and inner lining can each be affected in different ways. Myocardial degeneration is a broad descriptor, while pericarditis, myocarditis, cardiomyopathy, infarction, endocarditis, and rheumatic heart disease name distinct conditions or processes.
Those differences matter because the symptoms, causes, and care are not interchangeable. Persistent or unexplained symptoms deserve a conversation with a healthcare professional, especially when they affect your daily routine or raise concern about your heart health.
Write down your symptoms and questions, then arrange a medical appointment if they persist or concern you.




